Form 4: Solid Biosciences' Chief Regulatory Officer Reports Stock Transactions

Jessie Hanrahan, Chief Regulatory Officer of Solid Biosciences Inc., reports the vesting and subsequent sale of restricted stock units to cover withholding taxes.

Summary

• On February 13, 2025, Jessie Hanrahan, Chief Regulatory Officer of Solid Biosciences Inc., vested 8,125 restricted stock units (RSUs).
• Following the vesting, 3,079 shares of common stock were sold on February 14, 2025, at a price of $3.96 per share to cover withholding taxes.
• These transactions were executed according to a pre-arranged plan adopted on August 16, 2024.
• After these transactions, Hanrahan directly owns 19,281 shares of Solid Biosciences Inc. common stock and 24,375 restricted stock units.

Sentiment

Score: 5

Explanation: This is a routine regulatory filing related to stock transactions by a company officer. It doesn't inherently indicate positive or negative sentiment, but rather reflects standard compensation practices and tax obligations.

Industry Context

This Form 4 filing is a routine disclosure related to executive compensation and stock ownership, common among publicly traded companies. It provides transparency into the transactions of company insiders.

Stakeholder Impact

• The sale of shares by an officer could have a minor, temporary impact on the stock price, but is unlikely to be significant given the context of tax obligations.

Key Dates